PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE136.55-0.8 (-0.58 %)
PREV CLOSE ( ) 137.35
OPEN PRICE ( ) 137.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3316
TODAY'S LOW / HIGH ( )134.70 137.95
52 WK LOW / HIGH ( )113.55 202.2
NSE136.40-1.05 (-0.76 %)
PREV CLOSE( ) 137.45
OPEN PRICE ( ) 135.80
BID PRICE (QTY) 136.40 (971)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 99265
TODAY'S LOW / HIGH( ) 134.70 137.90
52 WK LOW / HIGH ( )114.2 202.5
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1984
Management Info
Rajesh Jain - Chairman Rajesh Jain - Managing Director
Registered Office

Address Ambala - Chandigarh Highway,,,
Lalru,
Punjab-140501

Phone 01762- 505900

Email companysec@panaceabiotec.com

Website www.panaceabiotec.com

Registrars Details
Skyline Financial Services Pvt Ltd
D-153/A, 1st Floor,Okhla Industrial Area,Phase - I,New Delhi
Listing : BSE, NSE, MCX
NEWS
05Apr Panacea Biotec informs about details o
With reference to CDSL’s Operating Instructions for Issuers/RTAs which s..
13Mar Panacea Biotec informs about newspaper
In continuation to letter dated March 12, 2024 and pursuant to Regulatio..
12Mar Panacea Biotec informs about notice of
Panacea Biotec has informed that it enclosed Postal Ballot Notice - Disc..
30Jan Panacea Biotec informs about board mee
Panacea Biotec has informed that meeting of the Board of Directors of th..
15Dec Panacea Biotec shines on launching ful
Panacea Biotec is currently trading at Rs. 170.40, up by 7.40 points or..
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit4.29999999999997-875.4
Gross Profit 10.7 -627.5
Operating Profit 96.9-281.9
Net Sales 952.32570.7
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Bharat Parenterals (BSE)
 1455.20 (10.00%)
M.Cap (Rs. in Cr)846.88
Solara Active Pharma (BSE)
 551.45 (16.32%)
M.Cap (Rs. in Cr)1985.01
Abbott India (BSE)
 26131.85 (0.29%)
M.Cap (Rs. in Cr)55528.36
Windlas Biotech (BSE)
 555.05 (6.97%)
M.Cap (Rs. in Cr)1154.42
Concord Biotech (BSE)
 1595.25 (1.05%)
M.Cap (Rs. in Cr)16688.90
Shareholding Pattern
PROMOTERS 73.59%
NON-INSTITUTION 25.3%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
Mf Holdings
Scheme NameHold(%)
Motilal Oswal S&P B...0.01
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.